New gene therapy cures 1st New Yorker of sickle cell anemia

Long Island patient gets breakthrough sickle cell treatment called a ‘cure’: ‘I’m not in pain anymore’
He’s got new blood. A Long Island hospital said it administered life-changing Lyfgenia gene therapy treatment and successfully wiped away sickle cell disease from a Laurelton man. Cohen Children’s Medical Center said patient Sebastien Beauzile,
Man becomes first in New York to be cured of sickle cell
LONG ISLAND, NY (WCBS) - A 21-year-old man has become the first in New York to be cured of sickle cell anemia. “We feel blessed to be the first to be able to offer this,” said Dr. Jonathan Fish with the Cohen Children’s Medical Center.
Sickle cell anemia patient reunites with Long Island doctors whose gene therapy treatments made him symptom-free
Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after undergoing Lyfgenia, a new type of gene therapy.
Long Island man is first in New York history to be cured of sickle cell anemia
A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. For 21 years, Sebastien Beauzile suffered chronic pain from debilitating sickle cell anemia.
'I'm Unstoppable': New gene therapy cures first New Yorker of sickle cell anemia
Thanks to his medical team, Sebastien is grateful for becoming the first person in New York to receive a new genetic treatment, Lyfgenia, to cure his sickle cell disease.
CNA1h
Ongoing R&D to reduce manufacturing costs of cell therapy treatments while ensuring quality
Singapore is using cell therapy to transform its cancer treatments. Doctors say it offers relapsed patients a 50 per cent ...
MaxCyte: Strong Revenues, Fast-Growing Cell-Therapy Market, Very Low Share Price
MaxCyte, Inc. is rated a "Buy" due to significant upside potential despite recent share price declines. Find out why.
Multiple Sclerosis News Today17h
Patients on B-cell therapies less likely to stop treatment: Study
MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...
Medindia11h
HIV Cure Closer? Scientists Discovers New Way to Trace Dormant HIV Cells
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
Managed Healthcare Executive2d
CAR T-Cell Therapy Cuts Costs, Reduces Treatment in Mantle Cell Lymphoma
In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...